retatrutide safety trial results Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease What caught my attention wasn't

While GLP-1 agonists are not prohibited, their use in weight-class sports raises ethical questions about artificially manipulating body weight for competitive advantage

It was the most effective antidiabetic agent anyone had ever seen, says Andrew Young, former vice president of research at Amylin Pharmaceuticals, the San Diegobased company that brought Byetta to market

If you have already achieved significant weight loss and are in a maintenance phase, you may be able to reduce your dose to a level that is more affordable at out-of-pocket prices

This scientific backing gave me a lot of confidence in trying them

Due to this triple receptor activity, Reta is being studied within advanced metabolism, energy, and glucose regulation research

Current clinical guidelines from major professional organizations provide evolving recommendations for pharmacologic management of weight regain after bariatric surgery